WallStreetZenWallStreetZen

NASDAQ: INDP
Indaptus Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Indaptus Therapeutics earnings were -$15.7M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest INDP earnings report on Jun 30, 2024 announced Q2 2024 earnings of -$4.0M, up 5.5% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, INDP reported annual earnings of -$15.4M, with 7.7% growth.

INDP earnings history

Current Revenue
$0.0
Current Earnings
-$15.7M
Current Profit Margin
0%

INDP Return on Equity

Current Company
-146.7%
Current Industry
22.8%
Current Market
33.7%
INDP's Return on Equity (-146.7%)... subscribe to Premium to read more.
High Return on Equity Performance

INDP Return on Assets

Current Company
-121.6%
Current Industry
3.5%
INDP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when INDP announces earnings.

INDP Return on Capital Employed

Current Company
-254.24%
Current Industry
21.3%
INDP's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

INDP vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
INDP-$15.75M-$15.75MN/A-$1.86
EVGN-$16.80M-$19.87MN/A-$3.92
CANF-$7.27M-$7.37MN/A-$3.00
IMRN-$4.78M-$4.78MN/A-$0.84
TENX-$12.54M-$12.57MN/A-$23.19
View Top Biotech Stocks

Indaptus Therapeutics Earnings Reports & History FAQ

What were Indaptus Therapeutics's earnings last quarter?

On INDP's earnings call on Invalid Date, Indaptus Therapeutics (NASDAQ: INDP) reported Q2 2024 earnings per share (EPS) of -$0.47, up 20.51% year over year. Total INDP earnings for the quarter were -$4.02 million. In the same quarter last year, Indaptus Therapeutics's earnings per share (EPS) was -$0.39.

If you're new to stock investing, here's how to buy Indaptus Therapeutics stock.

Is Indaptus Therapeutics profitable or losing money?

As of the last Indaptus Therapeutics earnings report, Indaptus Therapeutics is currently losing money. Indaptus Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$15.75 million, a 7.71% increase year over year.

What was INDP's earnings growth in the past year?

As of Indaptus Therapeutics's earnings date in Invalid Date, Indaptus Therapeutics's earnings has grown year over year. INDP earnings in the past year totalled -$15.75 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.